31.44
Overview
News
Price History
Option Chain
Financials
Why KDP Down?
Discussions
Forecast
Dividend History
Keurig Dr Pepper Inc. stock is traded at $31.44, with a volume of 13.70M.
It is up +1.03% in the last 24 hours and up +3.90% over the past month.
Keurig Dr Pepper Inc. engages in the brewing system and specialty coffee businesses in the United States and Canada. The company sources, produces, and sells coffee, hot cocoa, teas, and other beverages in K-Cup, Vue, Rivo, K-Carafe, and K-Mug pods brands; coffee in traditional packaging, including bags and fractional packs; and other specialty beverages in pods. It distributes its products through at-home and away-from-home channels to retailers, including supermarkets, department stores, mass merchandisers, club stores, and convenience stores; and restaurants, hospitality accounts, office coffee distributors, and partner brand owners, as well as to consumers through its Websites. The company was founded in 1981 and is based in Waterbury, Vermont. Keurig Dr Pepper Inc. is a subsidiary of Acorn Holdings B.V.
See More
Previous Close:
$31.12
Open:
$31.268
24h Volume:
13.70M
Relative Volume:
1.00
Market Cap:
$42.78B
Revenue:
$16.94B
Net Income/Loss:
$1.83B
P/E Ratio:
23.39
EPS:
1.3441
Net Cash Flow:
$1.44B
1W Performance:
+4.77%
1M Performance:
+3.90%
6M Performance:
+5.89%
1Y Performance:
-9.21%
Keurig Dr Pepper Inc. Stock (KDP) Company Profile
Name
Keurig Dr Pepper Inc.
Sector
Industry
Phone
-
Address
-
Compare KDP vs CCEP
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
KDP
Keurig Dr Pepper Inc.
|
31.44 | 40.23B | 16.94B | 1.83B | 1.44B | 1.3441 |
|
CCEP
Coca-Cola European Partners plc
|
107.64 | 47.32B | 23.61B | 2.24B | 2.13B | 4.8195 |
Keurig Dr Pepper Inc. Stock (KDP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-22-26 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Dec-17-25 | Downgrade | Jefferies | Buy → Hold |
| Dec-15-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-01-25 | Reiterated | TD Cowen | Hold |
| Sep-24-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Sep-22-25 | Downgrade | BNP Paribas Exane | Neutral → Underperform |
| Aug-26-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-25-25 | Upgrade | HSBC Securities | Hold → Buy |
| Apr-16-25 | Initiated | Argus | Buy |
| Apr-09-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-01-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-07-25 | Initiated | Piper Sandler | Neutral |
| Dec-12-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-23-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-24-24 | Initiated | Exane BNP Paribas | Neutral |
| Jun-17-24 | Upgrade | Truist | Sell → Hold |
| Jan-03-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-22-23 | Initiated | HSBC Securities | Hold |
| Nov-13-23 | Initiated | Jefferies | Buy |
| Aug-16-23 | Upgrade | UBS | Neutral → Buy |
| Jul-17-23 | Reiterated | JP Morgan | Overweight |
| Jul-06-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Feb-17-23 | Initiated | Citigroup | Neutral |
| Oct-31-22 | Downgrade | Truist | Hold → Sell |
| Oct-11-22 | Initiated | Wedbush | Outperform |
| Sep-27-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-21-22 | Downgrade | UBS | Buy → Neutral |
| Mar-22-22 | Downgrade | Truist | Buy → Hold |
| Jun-29-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-19-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-11-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-20-21 | Initiated | Bernstein | Outperform |
| Jan-06-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-08-20 | Initiated | Wells Fargo | Equal Weight |
| Aug-26-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-09-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-11-20 | Upgrade | Jefferies | Hold → Buy |
| Jun-01-20 | Upgrade | Evercore ISI | In-line → Outperform |
| Apr-01-20 | Resumed | Goldman | Neutral |
| Feb-24-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jul-17-19 | Initiated | Credit Suisse | Neutral |
| Jun-17-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-11-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-09-19 | Upgrade | Goldman | Neutral → Buy |
| Dec-21-18 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-13-18 | Initiated | UBS | Buy |
| Dec-07-18 | Initiated | SunTrust | Buy |
| Dec-04-18 | Upgrade | Macquarie | Neutral → Outperform |
| Nov-16-18 | Resumed | JP Morgan | Neutral |
View All
Keurig Dr Pepper Inc. Stock (KDP) Latest News
Is It Too Late to Buy Keurig Dr Pepper Inc (KDP) After 5.3% Rall - GuruFocus
Keurig Dr Pepper Inc. stock outperforms competitors on strong trading day - MarketWatch
Keurig Dr Pepper Shares Rise After HSBC Upgrade - marketscreener.com
Keurig Dr Pepper Gains as Investors Weigh Board Refresh and Separation Progress - Quiver Quantitative
Keurig Dr Pepper Inc. Stock 12‑Month Price Target Raised to $36.27, Implies 23% Upside - TradingView
Keurig Dr Pepper gains after HSBC points to upside (KDP:NASDAQ) - Seeking Alpha
Can JDE Peet's Become an Even Bigger Growth Driver for KDP? - TradingView
Keurig Dr Pepper (NASDAQ:KDP) Upgraded to Buy at HSBC - MarketBeat
Portillo’s New Cake Shake Blends Chocolate Cake With 23 Dr Pepper Flavors - Stock Titan
Portillo’s and Dr Pepper 'Shake” Things Up, Launching Limited-Time Shake and Cake Shake - The Manila Times
HSBC Upgrades Keurig Dr Pepper to Buy From Hold, Adjusts PT to $40 From $37 - marketscreener.com
Keurig Dr Pepper, Inc $KDP Holdings Raised by Handelsbanken Fonder AB - MarketBeat
Capital World Investors (NASDAQ: KDP) discloses 8.8% Keurig Dr Pepper stake - Stock Titan
Keurig Dr Pepper (KDP) Appoints Aaron Alt to Board of Directors - GuruFocus
Keurig Dr Pepper Expands Board, Names Aaron Alt as Independent Director - Kalkine Media
Coca-Cola Trades at a Valuation Premium: Justified or Overstretched? - TradingView
Keurig Dr Pepper Adds Cardinal Health CFO Aaron Alt to Board - citybiz
Keurig Dr Pepper appoints Aaron Alt to board of directors - Investing.com India
Keurig Dr Pepper appoints Aaron Alt to board of directors and audit committee - Investing.com
Keurig Dr Pepper appoints Aaron Alt to board of directors By Investing.com - Investing.com South Africa
Form 8K Keurig Dr Pepper Inc For: 12 August By Investing.com - Investing.com Canada
Aaron Alt appointed to Keurig Dr Pepper board, joins Audit and Finance Committee - TradingView
Keurig Dr Pepper (KDP) names Aaron Alt to board and Audit Committee - Stock Titan
Keurig Dr Pepper Inc. Announces Appointment of Aaron Alt as Director, Effective August 14, 2026 - marketscreener.com
Oakmark Select Fund's Keurig Dr Pepper Inc(KDP) Holding History - GuruFocus
Keurig Dr Pepper's 7Up leads with lime in its first brand refresh in 15 years (KDP:NASDAQ) - Seeking Alpha
Keurig Dr Pepper Inc. (KDP) Stock Forecasts - Yahoo Finance
Keurig Dr Pepper Inc. stock underperforms Monday when compared to competitors - MarketWatch
Keurig Dr Pepper Inc. Q2 2026: Revenue $7.31B, EPS $0.04— 10-Q Summary - TradingView
Keurig Dr Pepper (KDP) doubles sales with JDE Peet’s buy but profits fall - Stock Titan
Keurig Dr Pepper falsely advertises all natural ingredients in Nantucket Nectars, new class action lawsuit alleges - Claim Depot
Keurig Dr Pepper Faces Execution Risks as It Works to Separate Its Coffee and Beverages Businesses - Morningstar
7UP Puts Lime First as New Recipe Rolls Out Nationwide - Stock Titan
BNP Paribas Adjusts Price Target on Keurig Dr Pepper to $29 From $28, Maintains Neutral Rating - marketscreener.com
Katie Webb turns buzzy new flavors rooted in consumer insights into hits for Keurig Dr Pepper - Ad Age
Can Turning Point Brands Defend a "Dr. Pepper"‑Size Share After the FDA's Nicotine Pouch Decision? - The Motley Fool
Keurig Dr Pepper, Inc (NASDAQ:KDP) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Keurig Dr Pepper (NASDAQ:KDP) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
Keurig Dr Pepper Inc. stock underperforms Friday when compared to competitors - MarketWatch
Keurig Dr Pepper Earnings: Shares Fairly Valued as Separation Looms in Early 2027 - Morningstar
Keurig Dr Pepper Tops Q2 Estimates on Beverage Strength, Coffee Turnaround in Focus - finance.biggo.com
Keurig Dr Pepper's Q2 Results 'Solid' but US Coffee Underperforms, RBC Says - marketscreener.com
AMG River Road Mid Cap Value Fund's Keurig Dr Pepper Inc(KDP) Holding History - GuruFocus
Deutsche Bank Adjusts Keurig Dr Pepper Price Target to $32 From $30, Maintains Hold Rating - marketscreener.com
Pacer Advisors Inc. Sells 56,949 Shares of Keurig Dr Pepper, Inc $KDP - MarketBeat
Keurig Dr Pepper (KDP) Following Q2 Earnings Beat Is The Undervalued View Too Easy - Yahoo Finance
Keurig Dr Pepper Q2 Earnings Call Highlights - marketbeat.com
Keurig Dr Pepper Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Keurig Dr Pepper tops Q2 2026 forecasts as shares jump - Investing.com South Africa
Keurig Dr Pepper (NASDAQ:KDP) Posts Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Keurig Dr Pepper Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Keurig Dr Pepper Inc. Stock (KDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):